Reduction of the intraperitoneal inflammation associated with endometriosis by treatment with medroxyprogesterone acetate

article OA: closed CC0 ⤵ 34 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
AI-generated summary by claude@2026-06, 2026-06-09

Medroxyprogesterone acetate treatment reduced intraperitoneal inflammation in endometriosis patients.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Ascitic Fluid Endometriosis Medroxyprogesterone Peritoneal Neoplasms Peritonitis Adult Ascitic Fluid Ascitic Fluid Endometriosis Female Humans Leukocyte Count Medroxyprogesterone Menstrual Cycle Menstrual Cycle Menstruation Disturbances Menstruation Disturbances Peritoneal Neoplasms Peritonitis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (28)

Cited by (34)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:09:20.810540+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0 · commercial use OK